• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Crombie REIT
Infineon Techs Ag ADR
Nuclear Diamond Batteries Inc
State Street SPDR S&P Metals & Mining ETF
Edit Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Medaro Enters into Joint Venture Agreement to Develop Lithium Extraction Technology

By: Medaro Mining Corp. via AccessWire
June 30, 2021 at 20:10 PM EDT
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

VANCOUVER, BC / ACCESSWIRE / June 30, 2021 / Medaro Mining Corp. (CSE:MEDA) (“Medaro” or the “Company”) is pleased to announce, further to its news release dated May 6, 2021, that it has entered a definitive joint venture agreement (the “JV Agreement”) with Dr. James G. Blencoe, Ph.D., of Tennessee USA, and Global Lithium Extraction Technologies Inc. (“Global Lithium”), with respect to the operation of a joint venture (the “Joint Venture”) to develop and commercialize a new, low-cost process (the “Technology”) for extracting lithium from spodumene concentrate. The Joint Venture will be operated through Global Lithium, a new corporation that was formed for this purpose. For further information respecting the Technology and Dr. Blencoe’s background, please see the Company’s news release dated May 6, 2021.

Pursuant to the JV Agreement, Dr. Blencoe will contribute his and his related companies’ intellectual property, personnel, laboratory facilities and services to the Joint Venture and Medaro will fund the research and development costs of the Joint Venture through (i) the contribution of US$500,000 over the first ten (10) months of the Joint Venture and (ii) the contribution of up to US$3,000,000 towards commissioning of a pre-commercial facility for the large-scale testing and implementation of the Technology (the “Pilot Plant”). Medaro will acquire an ownership interest in Global Lithium in stages, as certain cash contributions are made, as the Joint Venture achieves certain operational and research milestones and upon Medaro issuing up to an aggregate of 1,850,000 common shares of Medaro to Dr. Blencoe. Once Medaro owns 80% of Global Lithium’s shares and the Pilot Plant has been completed, Medaro will be entitled to acquire remaining 20% interest in Global Lithium from Dr. Blencoe for US$10,000,000.

Pursuant to the JV Agreement, on completion of the Initial Earn-In, Dr. Blencoe will also join Medaro’s leadership team as Chief Technology Officer.

Additionally, the Company has entered into an agreement with Financial Star News Inc. (FSN), pursuant to which FSN will provide the Company with marketing services for an aggregate of USD$500,000. FSN will utilize their online programs with the aim of generating a greater following, increasing investor awareness and attracting potential new investors through various online platforms and methods of engagement.

About the Company 
The Company is a lithium exploration company based in Vancouver, BC and holds options over the Superb Lake lithium property located in Thunder Bay, Ontario and the CYR South lithium property located in James Bay, Quebec.

For more information, investors should review the Company’s filings that are available at www.sedar.com.

Forward-Looking Statements
This news release contains certain forward-looking statements that are “forward looking information” within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, including statements regarding the Joint Venture Agreement and the development of the Technology, the funding of the Joint Venture and the timing for same and the appointment of Dr. Blencoe as Chief Technology Officer of Medaro are "forward-looking information". These forward-looking statements reflect the expectations or beliefs of management of the Company based on information currently available to it. Forward-looking statements are subject to a number of risks and uncertainties, including those detailed from time to time in filings made by the Company with securities regulatory authorities, which may cause actual outcomes to differ materially from those discussed in the forward-looking statements. Relevant risks include the ability of the Joint Venture to develop the Technology as they intend and within the expected time frame, and the ability of Medaro to raise the funds necessary to fund development of the Technology and earn into the Joint Venture. These factors should be considered carefully and readers are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements and information contained in this news release are made as of the date hereof and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws.

Contact Information
Hugh Maddin
Director and CEO
Telephone:  604 602 0001
Email: info@medaromining.com 

SOURCE: Medaro Mining Corp.



View source version on accesswire.com:
https://www.accesswire.com/653840/Medaro-Enters-into-Joint-Venture-Agreement-to-Develop-Lithium-Extraction-Technology

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More
News headline image
NORMA Group Unveils New Strategy Targeting 10%+ EBIT Margin by 2031 ↗
Today 14:02 EDT
Via MarketBeat
News headline image
Rapport Therapeutics’ RAP-219 Hits Phase II Goals in Bipolar Mania Trial ↗
Today 13:02 EDT
Via MarketBeat
Tickers RAPP
News headline image
Newmont’s Record Quarter Shows Why Gold’s Floor Is the Real Story ↗
Today 12:05 EDT
Via MarketBeat
Tickers B NEM
News headline image
Odyssey Therapeutics Highlights OD-001 Phase IIa UC Data, Sets 2027 Trial Readouts ↗
Today 12:02 EDT
Via MarketBeat
Tickers ODTX
News headline image
Albemarle Upgrade: Can Energy Storage Recharge Lithium’s Leader? ↗
Today 11:15 EDT
Via MarketBeat
Tickers ALB

Recent Quotes

View More
Symbol Price Change (%)
AMZN  248.00
-2.38 (-0.95%)
AAPL  347.73
-0.50 (-0.14%)
AMD  516.79
+8.86 (1.74%)
BAC  50.56
-0.52 (-1.02%)
GOOG  317.28
-3.48 (-1.08%)
META  642.62
-6.23 (-0.96%)
MSFT  524.51
+3.43 (0.66%)
NVDA  210.96
-1.25 (-0.59%)
ORCL  126.16
+0.62 (0.49%)
TSLA  372.22
-2.36 (-0.63%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap